# A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective?

> **NCT02106234** · NA · COMPLETED · sponsor: **Maastricht University Medical Center** · enrollment: 660 (actual)

## Conditions studied

- Contrast Induced Nephropathy
- Acute Kidney Injury

## Interventions

- **OTHER:** No prophylactic iv hydration

## Key facts

- **NCT ID:** NCT02106234
- **Lead sponsor:** Maastricht University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-07
- **Final completion:** 2017-08
- **Target enrollment:** 660 (ACTUAL)
- **Last updated:** 2017-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02106234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02106234, "A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective?". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02106234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*